Matrixx Initiatives identifies new VP marketing for Zicam Cold Remedy brand
BRIDGEWATER, N.J. — Matrixx Initiatives recently named Lori Norian VP marketing for the Zicam Cold Remedy brand.
Norian previously worked at Unilever and has worked on popular products including Hellman’s, Ragu, Bertolli and Altoids. Norian said she believes her experience translates well to the cold remedy brand, which is targeted primarily to women.
“Knowing how to tap into consumers’ needs and develop resonant messaging and communications strategies is the key to driving further growth for Zicam,” Norian said.
Norian said the company’s small size and single-brand focus appealed to her as her opportunity to truly run a business. The new VP joins an all-female sales team, headed by CEO M’Lou Arnett.
“I knew Lori had one of the best minds in the industry, and I had heard of what she had done over the years with other brands,” Arnett said. “She has unparalleled knack for planning and developing a campaign, and we’re very fortunate to call her one of our own here at Zicam.”
Norian is currently developing activations for the upcoming cold season starting this November, spanning TV, print and digital media; social media activations; consumer experiential and sampling; and in-store campaigns.
“I’m getting settled in fast, but then again, I have to — the Cold Monster is coming,” Norian said, referring to the character in the Zicam advertising campaign.
Mark McClellan joins J&J board
NEW BRUNSWICK, N.J. — Johnson & Johnson on Monday announced that Mark McClellan, senior fellow in economic studies and director of the Initiative on Value and Innovation in Health Care at the Brookings Institution, will join the company’s board of directors on Oct. 15. McClellan will serve on the regulatory, compliance and government affairs committee, as well as the science, technology and sustainability committee.
As former commissioner of the Food and Drug Administration from 2002 to 2004, and as the former administrator of the Centers for Medicare & Medicaid Services for the Department of Health and Human Services from 2004 to 2006, McClellan has more than two decades of public service and academic research experience. From 2001 to 2002, he served as a member of the President’s Council of Economic Advisers and senior director for healthcare policy at the White House. During President Bill Clinton’s administration, McClellan held the position of deputy assistant secretary of the Treasury for economic policy.
"McClellan has a distinguished record in the public sector, as well as a deep understanding and vision for the future of health care," noted Alex Gorsky, chairman and CEO of Johnson & Johnson. "Mark shares our aspiration to help people live longer, healthier and happier lives and personally is committed to improving health care across the globe. He will be a valued leader on our board."
While at FDA, McClellan implemented the Critical Path Initiative, regulatory reforms to modernize pharmaceutical manufacturing and new initiatives on food safety and security. He has also led the development of performance-based healthcare payment reforms, insurance coverage reforms and a range of public-private initiatives to help improve care and lower costs.
McClellan previously served as an associate professor of economics and medicine with tenure at Stanford University, where he also directed the Program on Health Outcomes Research. Among other well-known health organizations in which he holds positions, he is the chair of the Clinician Measure Applications Partnership for the National Quality Forum. McClellan has received the Kenneth J. Arrow Award twice for Outstanding Research in Health Economics.
A 1985 graduate of the University of Texas at Austin, McClellan earned his M.D. degree at the Harvard University–Massachusetts Institute of Technology Division of Health Science and Technology, and his MPA at the Kennedy School of Government at Harvard. He earned his PhD in Economics at MIT and completed his residency in internal medicine at Brigham and Women’s Hospital in Boston.
National Consumers League targets teens with education around the risks of misusing OTC pain medications
WASHINGTON — The National Consumers League on Friday launched a national multimedia campaign aimed at educating teens and young adults about the risks of misusing OTC pain medications.
“When it comes to safety and health, teens often think they know more than they actually do,” stated Sally Greenberg, NCL executive director. “We have found teens as young as 13 years old, uninformed and self-medicating with OTC medications. And, while many teens do look to their parents and other adults for counsel and instruction about using OTC medications, many adult consumers aren’t properly using the medications themselves, setting a bad example for their children, and putting themselves at risk of serious health consequences.”
According to a survey released by NCL, nearly as many American teenagers (75%) as adults (84%) have used OTC pain medications in the past year. Approximately two-in-three of teen respondents (64%) said they have used an OTC pain medication in the last six months, most commonly for headaches, sports or exercise-related pain and muscle aches, or menstrual pain.
The survey also found that the incidence of use of OTC pain medications daily or several times per week is 15% among 13- to 15-year-olds, and 21% of 16- and 17-year-olds report using OTC pain medications at least several times a week.
NCL is launching TakeWithCare.org, an interactive site for teens to educate them about the safe use of OTC pain medications. TakeWithCare addresses some of the most common misconceptions about the safety of the medications: the importance of reading and following labels, taking the labeled dose and consulting with parents and healthcare professionals.
NCL also has created new OTC safety curriculum for its LifeSmarts program, a national consumer education competition and in-classroom aid for middle and high school students, and is today releasing the research about teen use of OTC medications that was used in the development of the new site. For more information about the survey, click here.
“The opportunity to educate teens about proper OTC pain medication use exists when they are young and have the potential to form better habits than their adult counterparts,” commented Rebecca Burkholder, NCL VP health policy. “As teens age and enter adulthood, they are using OTC pain medications more frequently and with increasingly less adult supervision. While we were pleased to see that the majority of teens are consulting a parent or guardian about such medication use, the goal of TakeWithCare is to instill good habits across the board.”